BDNF and neurodegenerative disease: Neurotrophins have been explored as therapeutic targets for neurodegenerative diseases, with strategies including gene therapy, small-molecule mimetics, peptidomimetics, and nanoparticle-based delivery systems to enhance their stability and blood–brain barrier permeability [23,24,25].